Test, Data, Treatment: Biotech's Guide to a Successful Diagnostic-Informed Therapy Launch
Whether you're in pre-seed, navigating early clinical trials, or preparing for commercial launch, this session is built for you.
Join Diaceutics for an exclusive 45-minute Lunch & Learn with Kevin Entwistle, SVP of Precision Medicine Strategy Services and former leader at Johnson & Johnson, Qiagen, and Leica Biosystems. With insights from over 125 therapy launches, Kevin will walk you through what works - and what derails it - when bringing precision therapies to market.
This session is tailored for biotech professionals across oncology, rare disease, and other therapeutic areas, whether you're on the research or commercial side of the business.
What you’ll gain in just 45 minutes:
Proven strategies from top pharma and biotech launches
How to integrate diagnostics from Day 1
How to build a tech and data infrastructure that empowers field teams
How to overcome testing, access, and adoption hurdles
Real-world case studies and lessons learned from the biggest brands in the industry
Tools needed and key stakeholders to engage
You’ll leave with:
Actionable insights to inform your strategy
Networking opportunities with peers in the field
And yes - a delicious lunch on us
Agenda:
Join Diaceutics for a Lunch & Learn at the prestigious Royal Sonesta Boston, just steps away from Kendall Square.
Doors open at 12pm. Lunch and refreshments are on us!
Lunch - Available from 12pm
Presentation - 12:40-1:25pm
Networking -1:25-2:30pm
About the Speaker
Before joining Diaceutics, Kevin Entwistle held leadership roles at Johnson & Johnson, Qiagen, and Leica Biosystems, where he supported global launches across oncology, neurology, immunology, cardiovascular, and rare diseases. With over 15 years’ experience in the IVD and pharmaceutical industry, Kevin has focused on commercial strategy, the commercialization of CDx in alignment with Rx launch and life cycle management across global territories, and regulatory approvals of IVDs including PMAs.
Now as SVP of Precision Medicine Strategy Services at Diaceutics, Kevin helps top pharmaceutical and biotech companies launch precision therapies with clarity and confidence.
LinkedIn profile: https://www.linkedin.com/in/kevin-entwistle-73335520/
About Diaceutics
Diaceutics partners with the world’s leading pharma and biotech companies to deliver end-to-end commercialization solutions for precision medicine. Supporting cross-functional teams in commercial, marketing, medical, data, access, and more, we deliver the insight and precision needed to move faster and reach every eligible patient.
From oncology and rare disease to neurology, autoimmune, and beyond – we can help you unlock uptake with smarter strategy, real-time physician action, and measurable impact. Diaceutics maintains the world’s largest repository of diagnostic testing data for precision medicine, powered by a network of >1500 labs across 51 countries.